-
1
-
-
0036680314
-
Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial
-
Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53:1097-1105.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 1097-1105
-
-
Pollack, A.1
Zagars, G.K.2
Starkschall, G.3
-
2
-
-
24644443217
-
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial
-
Zietman A.L., DeSilvio M.L., Koper P.C., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005, 294:1233-1239.
-
(2005)
JAMA
, vol.294
, pp. 1233-1239
-
-
Zietman, A.L.1
DeSilvio, M.L.2
Koper, P.C.3
-
3
-
-
33646462895
-
Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
-
Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24:1990-1996.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1990-1996
-
-
Peeters, S.T.1
Heemsbergen, W.D.2
Koper, P.C.3
-
4
-
-
34249316816
-
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial
-
Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007, 8:475-487.
-
(2007)
Lancet Oncol
, vol.8
, pp. 475-487
-
-
Dearnaley, D.P.1
Sydes, M.R.2
Graham, J.D.3
-
5
-
-
33846203312
-
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
-
Zelefsky M.J., Kuban D.A., Levy D.B., et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007, 67:327-333.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 327-333
-
-
Zelefsky, M.J.1
Kuban, D.A.2
Levy, D.B.3
-
6
-
-
33748294108
-
High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study
-
Vargas C.E., Martinez A.A., Boike T.P., et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study. Int J Radiat Oncol Biol Phys 2006, 66:416-423.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 416-423
-
-
Vargas, C.E.1
Martinez, A.A.2
Boike, T.P.3
-
7
-
-
14544289582
-
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
-
Sathya J.R., Davis I.R., Julian J.A., et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 2005, 23:1192-1199.
-
(2005)
J Clin Oncol
, vol.23
, pp. 1192-1199
-
-
Sathya, J.R.1
Davis, I.R.2
Julian, J.A.3
-
8
-
-
4644354413
-
Iodine 125 versus palladium 103 implants for prostate cancer: Clinical outcomes and complications
-
Peschel R.E., Colberg J.W., Chen Z., et al. Iodine 125 versus palladium 103 implants for prostate cancer: Clinical outcomes and complications. Cancer J 2004, 10:170-174.
-
(2004)
Cancer J
, vol.10
, pp. 170-174
-
-
Peschel, R.E.1
Colberg, J.W.2
Chen, Z.3
-
9
-
-
28444485693
-
I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial
-
Herstein A., Wallner K., Merrick G., et al. I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial. Cancer J 2005, 11:385-389.
-
(2005)
Cancer J
, vol.11
, pp. 385-389
-
-
Herstein, A.1
Wallner, K.2
Merrick, G.3
-
10
-
-
0344395011
-
125I versus 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial
-
Wallner K., Merrick G., True L., et al. 125I versus 103Pd for low-risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 2003, 57:1297-1303.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 1297-1303
-
-
Wallner, K.1
Merrick, G.2
True, L.3
-
11
-
-
33845627723
-
Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer
-
Zelefsky M.J., Yamada Y., Cohen G.N., et al. Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2007, 67:65-70.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 65-70
-
-
Zelefsky, M.J.1
Yamada, Y.2
Cohen, G.N.3
-
12
-
-
30544440136
-
Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results
-
Stock R.G., Stone N.N., Cesaretti J.A., et al. Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys 2006, 64:525-533.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 525-533
-
-
Stock, R.G.1
Stone, N.N.2
Cesaretti, J.A.3
-
13
-
-
33745184874
-
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
-
Roach M., Hanks G., Thames H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006, 65:965-974.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 965-974
-
-
Roach, M.1
Hanks, G.2
Thames, H.3
-
14
-
-
0029065422
-
Advances in benign prostatic hyperplasia. The developmental and clinical utility of symptom scores
-
Barry M.J., O'Leary M.P. Advances in benign prostatic hyperplasia. The developmental and clinical utility of symptom scores. Urol Clin North Am 1995, 22:299-307.
-
(1995)
Urol Clin North Am
, vol.22
, pp. 299-307
-
-
Barry, M.J.1
O'Leary, M.P.2
-
15
-
-
0032323716
-
Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate
-
Terk M.D., Stock R.G., Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 1998, 160:1379-1382.
-
(1998)
J Urol
, vol.160
, pp. 1379-1382
-
-
Terk, M.D.1
Stock, R.G.2
Stone, N.N.3
-
16
-
-
0036499149
-
Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study
-
Locke J., Ellis W., Wallner K., et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int J Radiat Oncol Biol Phys 2002, 52:712-719.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 712-719
-
-
Locke, J.1
Ellis, W.2
Wallner, K.3
-
17
-
-
0034255980
-
Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer
-
Gelblum D.Y., Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2000, 48:119-124.
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.48
, pp. 119-124
-
-
Gelblum, D.Y.1
Potters, L.2
-
18
-
-
0036570302
-
Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy
-
Kang S.K., Chou R.H., Dodge R.K., et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002, 53:99-103.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 99-103
-
-
Kang, S.K.1
Chou, R.H.2
Dodge, R.K.3
-
19
-
-
0042889278
-
Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy
-
Albert M., Tempany C.M., Schultz D., et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 2003, 98:949-954.
-
(2003)
Cancer
, vol.98
, pp. 949-954
-
-
Albert, M.1
Tempany, C.M.2
Schultz, D.3
-
20
-
-
70349560041
-
Erectile function durability following permanent prostate brachytherapy
-
Taira A.V., Merrick G.S., Galbreath R.W., et al. Erectile function durability following permanent prostate brachytherapy. Int J Oncol Biol Phys 2009, 75:639-648.
-
(2009)
Int J Oncol Biol Phys
, vol.75
, pp. 639-648
-
-
Taira, A.V.1
Merrick, G.S.2
Galbreath, R.W.3
-
21
-
-
33845599085
-
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience
-
Sylvester J.E., Grimm P.D., Blasko J.C., et al. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int J Radiat Oncol Biol Phys 2007, 67:57-64.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 57-64
-
-
Sylvester, J.E.1
Grimm, P.D.2
Blasko, J.C.3
-
22
-
-
77956841520
-
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy
-
[Epub ahead of print]
-
Dattoli M., Wallner K., True L., et al. Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy. J Oncol 2010, [Epub ahead of print].
-
(2010)
J Oncol
-
-
Dattoli, M.1
Wallner, K.2
True, L.3
|